Zweig Di Menna Associates LLC Heron Therapeutics, Inc. Transaction History
Zweig Di Menna Associates LLC
- $951 Million
- Q3 2024
A detailed history of Zweig Di Menna Associates LLC transactions in Heron Therapeutics, Inc. stock. As of the latest transaction made, Zweig Di Menna Associates LLC holds 128,592 shares of HRTX stock, worth $199,317. This represents 0.03% of its overall portfolio holdings.
Number of Shares
128,592
Previous 128,592
-0.0%
Holding current value
$199,317
Previous $450,000
43.33%
% of portfolio
0.03%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding HRTX
# of Institutions
179Shares Held
121MCall Options Held
80.4KPut Options Held
94.9K-
Rubric Capital Management LP New York, NY26.7MShares$41.4 Million1.48% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA8.85MShares$13.7 Million0.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.72MShares$13.5 Million0.0% of portfolio
-
Black Rock Inc. New York, NY8.33MShares$12.9 Million0.0% of portfolio
-
Velan Capital Investment Management LP Alpharetta, GA6.99MShares$10.8 Million28.8% of portfolio
About HERON THERAPEUTICS, INC.
- Ticker HRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 118,774,000
- Market Cap $184M
- Description
- Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single a...